SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-044691
Filing Date
2018-08-14
Accepted
2018-08-14 16:21:42
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv500081_10q.htm 10-Q 570699
2 EXHIBIT 10.35 tv500081_ex10-35.htm EX-10.35 23351
3 EXHIBIT 10.36 tv500081_ex10-36.htm EX-10.36 34212
4 EXHIBIT 10.37 tv500081_ex10-37.htm EX-10.37 25576
5 EXHIBIT 10.38 tv500081_ex10-38.htm EX-10.38 23357
6 EXHIBIT 31.1 tv500081_ex31-1.htm EX-31.1 10182
7 EXHIBIT 31.2 tv500081_ex31-2.htm EX-31.2 10046
8 EXHIBIT 32.1 tv500081_ex32-1.htm EX-32.1 5067
  Complete submission text file 0001144204-18-044691.txt   5081161

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT acur-20180630.xml EX-101.INS 1129775
10 XBRL TAXONOMY EXTENSION SCHEMA acur-20180630.xsd EX-101.SCH 49962
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20180630_cal.xml EX-101.CAL 37738
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20180630_def.xml EX-101.DEF 315198
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20180630_lab.xml EX-101.LAB 354453
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20180630_pre.xml EX-101.PRE 356502
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 181017878
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1